These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 32255293)

  • 1. Correlation between Chemokine CXCL-12 and ist Receptor CXCR4 Expression is Associated with Clinical Prognosis of Gastric Cancer.
    Xu G; Lu K; Shen M; Zhang Q; Pan W; Tang Z
    Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer.
    Wu W; Qian L; Chen X; Ding B
    Int J Clin Exp Pathol; 2015; 8(10):13217-24. PubMed ID: 26722521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of chemokine receptors in human gastric cancer.
    Kwak MK; Hur K; Park DJ; Lee HJ; Lee HS; Kim WH; Lee KU; Choe KJ; Yang HK
    Tumour Biol; 2005; 26(2):65-70. PubMed ID: 15867478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of chemokine stromal cell derived factor-1 and its receptor CXCR4 on the peritoneal carcinometastasis of gastric cancer].
    Ding YL; Zhang JL; Tang SF; Fu QY; Li ZT
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):202-5. PubMed ID: 18361822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular CXCR4 expression - a novel antiangiogenic target in gastric cancer?
    Ingold B; Simon E; Ungethüm U; Kuban RJ; Müller BM; Lupp A; Neumann U; Ebert MP; Denkert C; Weichert W; Schulz S; Röcken C
    PLoS One; 2010 Apr; 5(4):e10087. PubMed ID: 20386750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of CXCL12 and CXCR4 in gastric cancer and their correlation to lymph node metastasis.
    Ying J; Xu Q; Zhang G; Liu B; Zhu L
    Med Oncol; 2012 Sep; 29(3):1716-22. PubMed ID: 21630055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine receptor CXCR4 and its ligand CXCL12 expressions and clinical significance in bladder cancer.
    Yang DL; Xin MM; Wang JS; Xu HY; Huo Q; Tang ZR; Wang HF
    Genet Mol Res; 2015 Dec; 14(4):17699-707. PubMed ID: 26782415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer.
    Lee HJ; Kim SW; Kim HY; Li S; Yun HJ; Song KS; Kim S; Jo DY
    Int J Oncol; 2009 Feb; 34(2):473-80. PubMed ID: 19148483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A chemokine/chemokine receptor signature potentially predicts clinical outcome in colorectal cancer patients.
    Mitchell A; Hasanali SL; Morera DS; Baskar R; Wang X; Khan R; Talukder A; Li CS; Manoharan M; Jordan AR; Wang J; Bollag RJ; Singh N; Albo D; Ghosh S; Lokeshwar VB
    Cancer Biomark; 2019; 26(3):291-301. PubMed ID: 31524146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the CXCR4/CXCL12 axis and its clinical implications in gastric cancer.
    Lee HJ; Jo DY
    Histol Histopathol; 2012 Sep; 27(9):1155-61. PubMed ID: 22806902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression Patterns of CXCL12 and its Receptor in Colorectal Carcinoma.
    Mousavi A; Hashemzadeh S; Bahrami T; Estiar MA; Feizi MAH; Pouladi N; Rostamizadeh L; Sakhinia E
    Clin Lab; 2018 May; 64(5):871-876. PubMed ID: 29739049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated expression of C-X-C chemokine receptor 4 is an independent prognostic predictor for patients with gastric cancer.
    He H; Wang C; Shen Z; Fang Y; Wang X; Chen W; Liu F; Qin X; Sun Y
    PLoS One; 2013; 8(8):e71864. PubMed ID: 23936528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokine receptor 4 expression is correlated with the occurrence and prognosis of gastric cancer.
    Li Y; Wang HC; Wang JS; Sun B; Li LP
    FEBS Open Bio; 2020 Jun; 10(6):1149-1161. PubMed ID: 32306562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and significance of chemokine CXCL12 and receptor CXCR4 in adenomyosis].
    Wang S; Duan H; Li BH; Wang YY; Huang JH; Guo ZC
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):754-759. PubMed ID: 33228346
    [No Abstract]   [Full Text] [Related]  

  • 16. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CXCL12 and CXCR4 in pT3-stage gastric cancer does not correlate with peritoneal metastasis.
    Tsuboi K; Kodera Y; Nakanishi H; Ito S; Mochizuki Y; Nakayama G; Koike M; Fujiwara M; Yamamura Y; Nakao A
    Oncol Rep; 2008 Nov; 20(5):1117-23. PubMed ID: 18949410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of genetic polymorphisms of CXCL12/SDF1 gene and its receptor, CXCR4, to the susceptibility and prognosis of non-small cell lung cancer.
    Lee YL; Kuo WH; Lin CW; Chen W; Cheng WE; Chen SC; Shih CM
    Lung Cancer; 2011 Aug; 73(2):147-52. PubMed ID: 21292343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A positive crosstalk between CXCR4 and CXCR2 promotes gastric cancer metastasis.
    Xiang Z; Zhou ZJ; Xia GK; Zhang XH; Wei ZW; Zhu JT; Yu J; Chen W; He Y; Schwarz RE; Brekken RA; Awasthi N; Zhang CH
    Oncogene; 2017 Sep; 36(36):5122-5133. PubMed ID: 28481874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear expression of chemokine receptor CXCR4 indicates poorer prognosis in gastric cancer.
    Masuda T; Nakashima Y; Ando K; Yoshinaga K; Saeki H; Oki E; Morita M; Oda Y; Maehara Y
    Anticancer Res; 2014 Nov; 34(11):6397-403. PubMed ID: 25368239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.